A Proposed Roadmap for Parkinson’s Disease Proof of Concept Clinical Trials Investigating Compounds Targeting Alpha-Synuclein

The convergence of human molecular genetics and Lewy pathology of Parkinson’s disease (PD) have led to a robust, clinical-stage pipeline of alpha-synuclein (α-syn)-targeted therapies that have the potential to slow or stop the progression of PD and other synucleinopathies. To facilitate the developm...

Descripción completa

Detalles Bibliográficos
Autores principales: Merchant, Kalpana M., Cedarbaum, Jesse M., Brundin, Patrik, Dave, Kuldip D., Eberling, Jamie, Espay, Alberto J., Hutten, Samantha J., Javidnia, Monica, Luthman, Johan, Maetzler, Walter, Menalled, Liliana, Reimer, Alyssa N., Stoessl, A. Jon, Weiner, David M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: IOS Press 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398545/
https://www.ncbi.nlm.nih.gov/pubmed/30400107
http://dx.doi.org/10.3233/JPD-181471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398545/
https://www.ncbi.nlm.nih.gov/pubmed/30400107
http://dx.doi.org/10.3233/JPD-181471

Ejemplares similares